Extract notice to the Minister
Taltz
Common name / Subject : ixékizumab
Name of the manufacturer : Lilly
Form : Sol. Inj. S.C.
Dosage : 80 mg/mL (1 mL)
Name of the manufacturer : Lilly
Form : Sol. Inj. S.C.
Dosage : 80 mg/mL (1 mL)
Indication : Psoriasis en plaques
INESSS' Recommendation
-
Minister's decisions
Inscrire aux listes des médicaments - Médicament d’exception
Evaluation published on March 01, 2018